BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32710563)

  • 1. Epigenetic marker expression is of limited diagnostic utility in spitzoid melanocytic neoplasms.
    Yagi S; Balzer BL; Frishberg DP; Shon W
    J Cutan Pathol; 2020 Dec; 47(12):1228-1232. PubMed ID: 32710563
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to comment - Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphology.
    Zaremba A; Hadaschik E; Schadendorf D; Griewank K
    Eur J Cancer; 2021 Nov; 157():514-515. PubMed ID: 34579986
    [No Abstract]   [Full Text] [Related]  

  • 3. TERT promoter mutations are not always associated with poor prognosis in atypical spitzoid tumors.
    Requena C; Heidenreich B; Kumar R; Nagore E
    Pigment Cell Melanoma Res; 2017 Mar; 30(2):265-268. PubMed ID: 27930864
    [No Abstract]   [Full Text] [Related]  

  • 4. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical Spitz Tumors: A Diagnostic Challenge.
    Harms KL; Lowe L; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphology: Melanocytic tumours with Spitz-like morphology: toward a therapy-oriented diagnostic approach.
    Ferrara G; Rizzo N
    Eur J Cancer; 2021 Nov; 157():511-513. PubMed ID: 34389197
    [No Abstract]   [Full Text] [Related]  

  • 7. Melanocytic lesions, Spitz tumors, and Don Ferrante's logic.
    Urso C
    Am J Dermatopathol; 2007 Oct; 29(5):491-4. PubMed ID: 17890925
    [No Abstract]   [Full Text] [Related]  

  • 8. Ciliation Index Is a Useful Diagnostic Tool in Challenging Spitzoid Melanocytic Neoplasms.
    Lang UE; Torres R; Cheung C; Vladar EK; McCalmont TH; Kim J; Judson-Torres RL
    J Invest Dermatol; 2020 Jul; 140(7):1401-1409.e2. PubMed ID: 31978411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of neuropilin-2 as a simple and sensitive diagnostic assay for spitzoid melanocytic lesions.
    Eisenstein A; Panova IP; Chung HJ; Goldberg LJ; Zhang Q; Lazova R; Bhawan J; Busam KJ; Symanowski JT; Alani RM; Ryu B
    Melanoma Res; 2018 Feb; 28(1):71-75. PubMed ID: 29227334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
    Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
    Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAME Expression Correlates With Genomic Aberration and Malignant Diagnosis of Spitzoid Melanocytic Neoplasms.
    Gerami P; Benton S; Zhao J; Zhang B; Lampley N; Roth A; Boutko A; Olivares S; Busam KJ
    Am J Dermatopathol; 2022 Aug; 44(8):575-580. PubMed ID: 35503885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel H-RAS mutations identified in a child with an atypical spitzoid tumor.
    Simi L; Pinzani P; Salvianti F; Lorenzoni A; Tomasini C; Broganelli P; Orlando C; Pazzagli M; Massi D
    Arch Dermatol; 2011 Apr; 147(4):514-5. PubMed ID: 21482913
    [No Abstract]   [Full Text] [Related]  

  • 13. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
    Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
    Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
    Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
    Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analysis of melanocytic neoplasia.
    Bauer J; Bastian B
    Adv Dermatol; 2005; 21():81-99. PubMed ID: 16350439
    [No Abstract]   [Full Text] [Related]  

  • 16. Classic and atypical Spitz nevi: review of the literature.
    Helm TN; Helm KE
    Cutis; 2007 Sep; 80(3):183; author reply 183. PubMed ID: 17956003
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding spitzoid tumours: new insights from molecular pathology.
    Da Forno PD; Fletcher A; Pringle JH; Saldanha GS
    Br J Dermatol; 2008 Jan; 158(1):4-14. PubMed ID: 17916202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnostics for ambiguous melanocytic tumors.
    Shahbain H; Cooper C; Gerami P
    Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-phenotypical markers for the differential diagnosis of melanocytic lesions.
    Botti G; Marra L; Anniciello A; Scognamiglio G; Gigantino V; Cantile M
    Int J Clin Exp Pathol; 2015; 8(9):9742-51. PubMed ID: 26617684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview.
    Ferrara G; Gianotti R; Cavicchini S; Salviato T; Zalaudek I; Argenziano G
    Dermatol Clin; 2013 Oct; 31(4):589-98, viii. PubMed ID: 24075547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.